Ruiz-Cabello F, de la Higuera B, López Nevot M A, Huelin C, Conejo J M, Garrido F
Hybridoma. 1987 Jun;6(3):275-84. doi: 10.1089/hyb.1987.6.275.
The monoclonal antibody GR7A4 was produced against a human lymphoblastic leukemia (ALL-B). Biochemical characterization of GR7A4 was carried out with Raji cells in SDS-PAGE studies. GR7A4 precipitated a 43 kd molecule. The tissue distribution and molecular weight were similar to the T10 antigen. Modulation and capping of GR7A4 antigen reduced its binding ability to cells with either GR7A4 or OKT10. However, the cell surface distribution pattern observed was somewhat different from other similar monoclonal antibodies. Thus GR7A4 reacted greatly with pre-B-cell lines, Burkitt cell lines, EBV cell lines and activated PHA, ConA and PWM lymphocytes, however reactivity with leukemic cells was very limited. The kinetics of appearance of GR7A4 antigen on PWM blasts show that this molecule seems to represent an intermediate stage in lymphocytic activation. The differences in comparison with other similar MAbs are discussed and correlated with the peculiar discontinous pattern of appearance of this antigen.
单克隆抗体GR7A4是针对人淋巴细胞白血病(ALL - B)产生的。在SDS - PAGE研究中,用拉吉细胞对GR7A4进行了生化特性分析。GR7A4沉淀出一个43kd的分子。其组织分布和分子量与T10抗原相似。GR7A4抗原的调节和封帽降低了它与表达GR7A4或OKT10的细胞的结合能力。然而,观察到的细胞表面分布模式与其他类似单克隆抗体有所不同。因此,GR7A4与前B细胞系、伯基特细胞系、EBV细胞系以及活化的PHA、ConA和PWM淋巴细胞反应强烈,而与白血病细胞的反应非常有限。GR7A4抗原在PWM刺激的母细胞上出现的动力学表明,该分子似乎代表淋巴细胞活化的一个中间阶段。文中讨论了与其他类似单克隆抗体相比的差异,并将其与该抗原出现的特殊不连续模式相关联。